Search Results - "FAVALORO, J"

Refine Results
  1. 1

    Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia by Favaloro, Emmanuel J.

    “…COVID‐19 (coronavirus disease 2019) represents a pandemic, and several vaccines have been produced to prevent infection and/or severe sequelae associated with…”
    Get full text
    Journal Article
  2. 2

    Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests by Favaloro, Emmanuel J.

    Published in American journal of hematology (01-01-2020)
    “…Coagulation testing underpins the investigation of hemostasis and/or monitoring of anticoagulation therapy for prevention and/or treatment of thrombosis…”
    Get full text
    Journal Article
  3. 3

    Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History by Favaloro, Emmanuel J

    Published in Seminars in thrombosis and hemostasis (01-02-2024)
    “…There is no certainty in change, other than change is certain. As celebrates 50 years of publication, I felt it appropriate to reflect on my own 40-year plus…”
    Get more information
    Journal Article
  4. 4

    The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA) by Favaloro, Emmanuel J.

    Published in American journal of hematology (01-11-2019)
    “…Lupus anticoagulants (LAs) are a laboratory representation of the clinical syndrome of antiphospholipid syndrome (APS), and can also arise in other…”
    Get full text
    Journal Article
  5. 5

    COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? by Favaloro, Emmanuel J, Henry, Brandon Michael, Lippi, Giuseppe

    Published in Seminars in thrombosis and hemostasis (01-02-2022)
    “…Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential prothrombotic risk in several autoimmune conditions, most notably…”
    Get more information
    Journal Article
  6. 6

    Coronavirus Disease 2019–Associated Coagulopathy by Lippi, Giuseppe, Sanchis-Gomar, Fabian, Favaloro, Emmanuel J., Lavie, Carl J., Henry, Brandon M.

    Published in Mayo Clinic proceedings (01-01-2021)
    “…Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently found to suffer from both arterial and venous thrombotic events due…”
    Get full text
    Journal Article
  7. 7

    Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT) by Favaloro, Emmanuel J, Pasalic, Leonardo, Lippi, Giuseppe

    Published in Clinical chemistry and laboratory medicine (26-01-2022)
    “…Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In…”
    Get more information
    Journal Article
  8. 8

    Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges by Favaloro, Emmanuel J, Pasalic, Leonardo, Curnow, Jennifer, Lippi, Giuseppe

    Published in Current drug metabolism (01-07-2017)
    “…The Direct Oral Anticoagulants (DOACs) represent a new generation of antithrombotic agents, providing direct inhibition of either thrombin (factor IIa; FIIa)…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Autoimmune Diseases Affecting Hemostasis: A Narrative Review by Favaloro, Emmanuel J, Pasalic, Leonardo, Lippi, Giuseppe

    “…Hemostasis reflects a homeostatic mechanism that aims to balance out pro-coagulant and anti-coagulant forces to maintain blood flow within the circulation…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Towards improved diagnosis of von Willebrand disease: Comparative evaluations of several automated von Willebrand factor antigen and activity assays by Favaloro, Emmanuel J, Mohammed, Soma

    Published in Thrombosis research (01-12-2014)
    “…Abstract Introduction von Willebrand disease (VWD) is reportedly the most common bleeding disorder and arises from deficiency and/or defects of von Willebrand…”
    Get full text
    Journal Article
  13. 13

    Laboratory tests used to help diagnose von Willebrand disease: an update by Favaloro, Emmanuel J., Pasalic, Leonardo, Curnow, Jennifer

    Published in Pathology (01-06-2016)
    “…von Willebrand disease (VWD) is due to quantitative deficiencies and/or qualitative defects in von Willebrand factor (VWF), and is reportedly the most common…”
    Get full text
    Journal Article
  14. 14

    Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives by Favaloro, Emmanuel J., Mohammed, Soma, Curnow, Jennifer, Pasalic, Leonardo

    Published in Pathology (01-04-2019)
    “…We and others have previously highlighted the potential problems with testing of lupus anticoagulants (LA) in patients on anticoagulant therapy, including most…”
    Get full text
    Journal Article
  15. 15

    Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants by Favaloro, Emmanuel J., Pasalic, Leonardo

    “…Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples by Bonar, Roslyn, Favaloro, Emmanuel J., Mohammed, Soma, Ahuja, Monica, Pasalic, Leonardo, Sioufi, John, Marsden, Katherine

    Published in Pathology (01-01-2016)
    “…The direct oral anticoagulants (DOACs), now including dabigatran, apixaban and rivaroxaban, have given clinicians alternative options to low molecular weight…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia by Selvadurai, Maria V, Favaloro, Emmanuel J, Chen, Vivien M

    Published in Seminars in thrombosis and hemostasis (01-07-2023)
    “…Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high…”
    Get more information
    Journal Article
  20. 20

    Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies by Favaloro, Emmanuel J.

    “…14 The clinical utility of one VWF test method, multimer analysis, is featured in this issue of the journal. 15 Considered essential for VWD diagnosis and…”
    Get full text
    Journal Article